Avid Amyvid Could Be Approved If Training Improves, Advisory Committee Says

The Peripheral and Central Nervous System Drugs Advisory Committee demands a second voting question to say the data support approval of the amyloid plaque diagnostic, but not until more consistent interpretation methods are developed.